Ipamorelin
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue developed by Novo Nordisk and described in 1998 as the first selective GH secretagogue. It was studied in animal models and reached phase II clinical trials for postoperative ileus, which were stopped for lack of efficacy.
- Class
- growth hormone secretagogue (ghrelin receptor agonist)
- Type
- peptide, 5 residues
- Also known as
- NNC 26-0161
- Sequence
Aib-His-D-2Nal-D-Phe-Lys-NH2- Molecular formula
- C38H49N9O5
- Molecular weight
- 711.9 g/mol
- CAS number
- 170851-70-4
- PubChem CID
- 20754357
- First described
- 1998: Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology 139(5):552–561.
Regulatory status
Not an approved medicine. FDA placed ipamorelin acetate in category 2 (potential significant safety risks) for 503B outsourcing-facility compounding in September 2023.
SHLabz batch results
| Product | Batch | Purity | Amount measured | Tested | Report |
|---|---|---|---|---|---|
| Ipamorelin 10 mg | IP10/2025-1010 | 99.616% | 10.25 mg | 03 Nov 2025 | Janoshik 85662 |
Where SHLabz supplies it
CJC-1295 (No DAC) + Ipamorelin · CJC-1295 (No DAC) + Ipamorelin Pen · CJC-1295 + Ipamorelin Nasal Spray. For laboratory research use only.
Further reading
Sources
- PubChem CID 20754357: Ipamorelin
- Cayman Chemical: Ipamorelin (item 39813): sequence with D-residues, references
- FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of 04/22/2026)
How to cite this sheet
SHLabz (2025). Ipamorelin: compound reference sheet. SHLabz Compound Library. https://shlabz.ae/compounds/ipamorelin/
This sheet describes a molecule and the published research on it. It is not advice about use, and SHLabz products are not for human or veterinary use.
The UAE & GCC’s Trusted Source for Lab‑Verified Research Peptides
Research-grade peptides at ≥99% purity, third-party HPLC tested and released against a certificate of analysis. 1–2 working days across the UAE, 3–5 across the GCC.
≥99% purity, third-party HPLC tested and released against a certificate of analysis. Dispatched the same working day.
Lab Tested ≥99% Purity



Every vial, ready to ship
Prices in AED. Order before 12:00 UAE time for same-day dispatch — after that, the next working day.
No batch is released without a certificate
Every production batch is tested by a third-party laboratory before release, and every certificate is published in our COA library.
- Reverse-phase HPLC and ESI mass spectrometry on every batch
- Every batch we release has its certificate published
- Lyophilised, sealed and packed to arrive intact
- Supplied strictly for laboratory research use
SH-R · Janoshik Analytical test report #122536
- Batch
- RT20/2026-0310
- Analysis conducted
- 19 Mar 2026
- Purity
- 99.868 %
- Content
- 20.76 mg
1 of 11
Explore Our Research Resources
Work out your reconstitution, build a pack from the catalogue, and explore educational articles created for the UAE & GCC research community.
Peptide Reconstitution Calculator
Work out vial strength, bacteriostatic water volume and the exact insulin-syringe measurement for your target amount.
Open the CalculatorBuild a Stack
Mix and match any research products into one pack and take a discount off every item in it.
Build a StackPeptide Learning Centre
Explore our peptide articles, research guides, and educational resources.
Start LearningNeed a hand?
The answers we give most often, or a direct line to a person.
Support hours: Monday to Friday, 9:00 AM–6:00 PM UAE time